A joint Zoloft birth defects lawsuit has been filed in California (CA) on behalf of seventeen children. The plaintiffs are from across the country. The children were born with serious birth defects including heart problems, spina bifida, and clubfoot after their mothers took Zoloft during their pregnancies.
The Zoloft lawsuit alleges that Pfizer “designed, manufactured and sold a potentially defective medicine without proper safety warnings as to in-utero side effects.” The mothers indicate they would not have taken Zoloft had they been warned about the health risks to their unborn children. One of the children died as a result of her severe birth defects.
Zoloft is in the Selective Serotonin Reuptake Inhibitor (SSRI) class of antidepressant medications. Pfizer markets Zoloft as a treatment for a variety of mental health conditions including social anxiety disorder, post-traumatic stress disorder, panic attacks, and obsessive-compulsive disorder. Approved for by the FDA use in the United States in 1992, Zoloft has been one of the most prescribed anti-depressant drugs. In 2006, a FDA warning about Zoloft and generic sertraline was issued to give notice to doctors and patients that Zoloft use during pregnancy can increase the risk of PPHN (persistent pulmonary hypertension of the newborn).
The families have filed multiple counts against Pfizer including negligence, negligent misrepresentation, fraud, deceit by concealment, breach of implied and express warranty and wrongful death. They are asking for damages for past and future medical expenses, pain and suffering, loss of companionship and punitive damages.